annual CFF:
$735.06M+$139.95M(+23.52%)Summary
- As of today (July 3, 2025), MDGL annual cash flow from financing activities is $735.06 million, with the most recent change of +$139.95 million (+23.52%) on December 31, 2024.
- During the last 3 years, MDGL annual CFF has risen by +$563.83 million (+329.27%).
- MDGL annual CFF is now at all-time high.
Performance
MDGL Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$8.64M-$11.13M(-56.30%)Summary
- As of today (July 3, 2025), MDGL quarterly cash flow from financing activities is $8.64 million, with the most recent change of -$11.13 million (-56.30%) on March 31, 2025.
- Over the past year, MDGL quarterly CFF has dropped by -$565.07 million (-98.49%).
- MDGL quarterly CFF is now -98.49% below its all-time high of $573.71 million, reached on March 31, 2024.
Performance
MDGL quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$170.00M-$565.07M(-76.87%)Summary
- As of today (July 3, 2025), MDGL TTM cash flow from financing activities is $170.00 million, with the most recent change of -$565.07 million (-76.87%) on March 31, 2025.
- Over the past year, MDGL TTM CFF has dropped by -$946.14 million (-84.77%).
- MDGL TTM CFF is now -85.92% below its all-time high of $1.21 billion, reached on June 30, 2024.
Performance
MDGL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MDGL Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.5% | -98.5% | -84.8% |
| 3 y3 years | +329.3% | +100.0% | +63.2% |
| 5 y5 years | +10000.0% | +100.0% | +10000.0% |
MDGL Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +329.3% | -98.5% | >+9999.0% | -85.9% | +147.8% |
| 5 y | 5-year | at high | >+9999.0% | -98.5% | >+9999.0% | -85.9% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -98.5% | +124.5% | -85.9% | +729.4% |
MDGL Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $8.64M(-56.3%) | $170.00M(-76.9%) |
| Dec 2024 | $735.06M(+23.5%) | $19.77M(+165.0%) | $735.06M(-38.5%) |
| Sep 2024 | - | $7.46M(-94.4%) | $1.20B(-1.0%) |
| Jun 2024 | - | $134.12M(-76.6%) | $1.21B(+8.2%) |
| Mar 2024 | - | $573.71M(+19.5%) | $1.12B(+87.5%) |
| Dec 2023 | $595.12M(+89.9%) | $479.92M(+2351.1%) | $595.12M(+56.8%) |
| Sep 2023 | - | $19.58M(-54.4%) | $379.54M(+5.4%) |
| Jun 2023 | - | $42.93M(-18.5%) | $359.96M(-1.7%) |
| Mar 2023 | - | $52.69M(-80.1%) | $366.14M(+16.8%) |
| Dec 2022 | $313.45M(+83.1%) | $264.34M(>+9900.0%) | $313.45M(+356.8%) |
| Sep 2022 | - | $0.00(-100.0%) | $68.62M(-23.5%) |
| Jun 2022 | - | $49.11M(>+9900.0%) | $89.72M(-13.9%) |
| Mar 2022 | - | $0.00(-100.0%) | $104.14M(-39.2%) |
| Dec 2021 | $171.24M(+3265.5%) | $19.50M(-7.6%) | $171.24M(+9.5%) |
| Sep 2021 | - | $21.10M(-66.8%) | $156.36M(+15.3%) |
| Jun 2021 | - | $63.54M(-5.3%) | $135.61M(+87.9%) |
| Mar 2021 | - | $67.09M(+1349.4%) | $72.18M(+1318.7%) |
| Dec 2020 | $5.09M(+2065.1%) | $4.63M(+1222.6%) | $5.09M(+1008.5%) |
| Sep 2020 | - | $350.00K(+221.1%) | $459.00K(+218.8%) |
| Jun 2020 | - | $109.00K(>+9900.0%) | $144.00K(-5.3%) |
| Mar 2020 | - | $0.00(0.0%) | $152.00K(-35.3%) |
| Dec 2019 | $235.00K(-99.9%) | $0.00(-100.0%) | $235.00K(-72.2%) |
| Sep 2019 | - | $35.00K(-70.1%) | $845.00K(-33.0%) |
| Jun 2019 | - | $117.00K(+41.0%) | $1.26M(-99.6%) |
| Mar 2019 | - | $83.00K(-86.4%) | $314.15M(-0.1%) |
| Dec 2018 | $314.33M(+80.9%) | $610.00K(+35.3%) | $314.33M(-30.0%) |
| Sep 2018 | - | $451.00K(-99.9%) | $449.25M(+0.1%) |
| Jun 2018 | - | $313.01M(>+9900.0%) | $448.80M(+163.0%) |
| Mar 2018 | - | $265.00K(-99.8%) | $170.67M(-1.8%) |
| Dec 2017 | $173.81M(+1102.5%) | $135.53M(>+9900.0%) | $173.81M(+292.9%) |
| Sep 2017 | - | $0.00(-100.0%) | $44.23M(-3.5%) |
| Jun 2017 | - | $34.88M(+926.2%) | $45.86M(+168.1%) |
| Mar 2017 | - | $3.40M(-42.9%) | $17.10M(+18.3%) |
| Dec 2016 | $14.45M(+338.0%) | $5.95M(+266.4%) | $14.45M(+46.7%) |
| Sep 2016 | - | $1.63M(-73.5%) | $9.85M(-136.5%) |
| Jun 2016 | - | $6.13M(+716.7%) | -$27.01M(-524.6%) |
| Mar 2016 | - | $750.00K(-44.4%) | $6.36M(+92.8%) |
| Dec 2015 | $3.30M | $1.35M(-103.8%) | $3.30M(-1019.2%) |
| Sep 2015 | - | -$35.24M(-189.2%) | -$359.00K(-100.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | $39.50M(-1809.1%) | $60.69M(-19.5%) |
| Mar 2015 | - | -$2.31M(+0.1%) | $75.37M(-11.6%) |
| Dec 2014 | $85.30M(+23.5%) | -$2.31M(-108.9%) | $85.30M(-41.0%) |
| Sep 2014 | - | $25.82M(-52.3%) | $144.46M(+22.0%) |
| Jun 2014 | - | $54.17M(+611.2%) | $118.43M(+84.0%) |
| Mar 2014 | - | $7.62M(-86.6%) | $64.38M(-6.8%) |
| Dec 2013 | $69.04M(-40.2%) | $56.85M(<-9900.0%) | $69.04M(-1.7%) |
| Sep 2013 | - | -$211.00K(-275.8%) | $70.26M(-25.6%) |
| Jun 2013 | - | $120.00K(-99.0%) | $94.42M(-0.3%) |
| Mar 2013 | - | $12.28M(-78.9%) | $94.75M(-18.0%) |
| Dec 2012 | $115.52M(+214.4%) | $58.07M(+142.5%) | $115.52M(+101.3%) |
| Sep 2012 | - | $23.95M(+5331.1%) | $57.37M(+72.4%) |
| Jun 2012 | - | $441.00K(-98.7%) | $33.29M(-50.8%) |
| Mar 2012 | - | $33.05M(<-9900.0%) | $67.68M(+84.2%) |
| Dec 2011 | $36.74M(-18.6%) | -$69.00K(-48.9%) | $36.74M(-12.3%) |
| Sep 2011 | - | -$135.00K(-100.4%) | $41.90M(-25.2%) |
| Jun 2011 | - | $34.84M(+1556.5%) | $55.99M(+167.8%) |
| Mar 2011 | - | $2.10M(-58.7%) | $20.91M(-53.7%) |
| Dec 2010 | $45.16M(-2221.0%) | $5.10M(-63.5%) | $45.16M(+13.8%) |
| Sep 2010 | - | $13.96M(-5750.2%) | $39.68M(+57.3%) |
| Jun 2010 | - | -$247.00K(-100.9%) | $25.22M(+1.4%) |
| Mar 2010 | - | $26.35M(-6980.2%) | $24.87M(-1268.2%) |
| Dec 2009 | -$2.13M(+11.7%) | -$383.00K(-24.2%) | -$2.13M(-11.3%) |
| Sep 2009 | - | -$505.00K(-14.6%) | -$2.40M(-7.7%) |
| Jun 2009 | - | -$591.00K(-9.1%) | -$2.60M(+13.0%) |
| Mar 2009 | - | -$650.00K(-0.5%) | -$2.30M(+20.7%) |
| Dec 2008 | -$1.91M(-104.3%) | -$653.00K(-7.2%) | -$1.91M(+25.2%) |
| Sep 2008 | - | -$704.00K(+140.3%) | -$1.52M(+62.1%) |
| Jun 2008 | - | -$293.00K(+14.5%) | -$939.00K(-14.5%) |
| Mar 2008 | - | -$256.00K(-4.8%) | -$1.10M(-102.5%) |
| Dec 2007 | $43.88M(+11.7%) | -$269.00K(+122.3%) | $43.88M(-0.6%) |
| Sep 2007 | - | -$121.00K(-73.2%) | $44.15M(-0.3%) |
| Jun 2007 | - | -$452.00K(-101.0%) | $44.27M(-1.0%) |
| Mar 2007 | - | $44.73M(-6667.5%) | $44.73M(-6667.5%) |
| Dec 2006 | $39.29M(+939.7%) | - | - |
| Dec 2005 | $3.78M(-95.5%) | - | - |
| Mar 2005 | - | -$681.00K | -$681.00K |
| Dec 2004 | $84.28M(+18.5%) | - | - |
| Dec 2003 | $71.12M | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual CFF year-on-year change?
- What is Madrigal Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly CFF year-on-year change?
- What is Madrigal Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM CFF year-on-year change?
What is Madrigal Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of MDGL is $735.06M
What is the all time high annual CFF for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual cash flow from financing activities is $735.06M
What is Madrigal Pharmaceuticals annual CFF year-on-year change?
Over the past year, MDGL annual cash flow from financing activities has changed by +$139.95M (+23.52%)
What is Madrigal Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of MDGL is $8.64M
What is the all time high quarterly CFF for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly cash flow from financing activities is $573.71M
What is Madrigal Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, MDGL quarterly cash flow from financing activities has changed by -$565.07M (-98.49%)
What is Madrigal Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of MDGL is $170.00M
What is the all time high TTM CFF for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM cash flow from financing activities is $1.21B
What is Madrigal Pharmaceuticals TTM CFF year-on-year change?
Over the past year, MDGL TTM cash flow from financing activities has changed by -$946.14M (-84.77%)